-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

ASH Guidelines on Venous Thromboembolism (VTE): What's New

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), Diseases, Therapies, Adverse Events
Monday, December 11, 2023: 4:30 PM-6:00 PM
Room 28 A-D (San Diego Convention Center)
Chair:
Adam Cuker, MD, MS, University of Pennsylvania
Disclosures:
No relevant conflicts of interest to declare.
This special education session will provide clinically-relevant updates to ASH's portfolio of guidelines on VTE, including the following:

  • Dr. Saskia Middeldorp will discuss practice-changing recommendations from the recently published ASH Guidelines on Thrombophilia
  • Dr. Deborah Siegal will discuss next steps regarding the ASH Guidelines on the Use of Anticoagulation in Patients with COVID-19
  • Dr. Suely Rezende will provide updates on the newest adaptations of ASH VTE guidelines for Latin America
ASH Guidelines on Thrombophilia

Saskia Middeldorp, MD, PhD

Academic Medical Center, Nijmegen, Netherlands
Next Steps for ASH Guidelines on Use of Anticoagulation in Patients with COVID-19

Deborah Siegal, MD, MSc

Department of Medicine, University of Ottawa, Ottawa, ON, Canada
Updates on Adaptation of ASH VTE Guidelines for Latin America

Suely M. Rezende, MD, PhD

Universidade Federal de Minas Gerais, BELO HORIZONTE, AC, Brazil
See more of: Special-Interest Sessions
<< Previous Session | Next Session >>